nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—atherosclerosis—type 2 diabetes mellitus	0.287	0.649	CtDrD
Ezetimibe—coronary artery disease—type 2 diabetes mellitus	0.155	0.351	CtDrD
Ezetimibe—ABCC2—type 2 diabetes mellitus	0.102	0.693	CbGaD
Ezetimibe—CYP3A4—type 2 diabetes mellitus	0.0451	0.306	CbGaD
Ezetimibe—UGT1A3—Irbesartan—type 2 diabetes mellitus	0.0303	0.122	CbGbCtD
Ezetimibe—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.0199	0.0805	CbGbCtD
Ezetimibe—UGT1A3—Losartan—type 2 diabetes mellitus	0.0195	0.0788	CbGbCtD
Ezetimibe—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.018	0.0728	CbGbCtD
Ezetimibe—ABCC3—Glyburide—type 2 diabetes mellitus	0.0178	0.0721	CbGbCtD
Ezetimibe—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.0166	0.0672	CbGbCtD
Ezetimibe—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.0147	0.0594	CbGbCtD
Ezetimibe—UGT2B7—Losartan—type 2 diabetes mellitus	0.0141	0.057	CbGbCtD
Ezetimibe—UGT1A1—Losartan—type 2 diabetes mellitus	0.0122	0.0492	CbGbCtD
Ezetimibe—SLCO1B1—Losartan—type 2 diabetes mellitus	0.00844	0.0341	CbGbCtD
Ezetimibe—ABCC2—Glyburide—type 2 diabetes mellitus	0.00811	0.0328	CbGbCtD
Ezetimibe—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00801	0.0324	CbGbCtD
Ezetimibe—ABCG2—Glyburide—type 2 diabetes mellitus	0.00733	0.0296	CbGbCtD
Ezetimibe—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00714	0.0288	CbGbCtD
Ezetimibe—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00516	0.0209	CbGbCtD
Ezetimibe—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0048	0.0194	CbGbCtD
Ezetimibe—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00428	0.0173	CbGbCtD
Ezetimibe—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00391	0.0158	CbGbCtD
Ezetimibe—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00355	0.0143	CbGbCtD
Ezetimibe—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00342	0.0138	CbGbCtD
Ezetimibe—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00309	0.0125	CbGbCtD
Ezetimibe—ABCB1—Glyburide—type 2 diabetes mellitus	0.00264	0.0107	CbGbCtD
Ezetimibe—ABCB1—Losartan—type 2 diabetes mellitus	0.00242	0.00977	CbGbCtD
Ezetimibe—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00234	0.00947	CbGbCtD
Ezetimibe—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00225	0.00908	CbGbCtD
Ezetimibe—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00225	0.00908	CbGbCtD
Ezetimibe—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00212	0.00859	CbGbCtD
Ezetimibe—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00158	0.0064	CbGbCtD
Ezetimibe—CYP3A4—Losartan—type 2 diabetes mellitus	0.00145	0.00585	CbGbCtD
Ezetimibe—ABCG5—liver—type 2 diabetes mellitus	0.0011	0.0598	CbGeAlD
Ezetimibe—NPC1L1—liver—type 2 diabetes mellitus	0.00103	0.0562	CbGeAlD
Ezetimibe—ABCG8—liver—type 2 diabetes mellitus	0.000978	0.0533	CbGeAlD
Ezetimibe—UGT2B15—islet of Langerhans—type 2 diabetes mellitus	0.000918	0.05	CbGeAlD
Ezetimibe—SOAT1—islet of Langerhans—type 2 diabetes mellitus	0.00079	0.043	CbGeAlD
Ezetimibe—ANPEP—islet of Langerhans—type 2 diabetes mellitus	0.000756	0.0412	CbGeAlD
Ezetimibe—SOAT1—retina—type 2 diabetes mellitus	0.000675	0.0368	CbGeAlD
Ezetimibe—UGT2B15—pancreas—type 2 diabetes mellitus	0.000646	0.0352	CbGeAlD
Ezetimibe—SOAT1—nephron tubule—type 2 diabetes mellitus	0.000636	0.0347	CbGeAlD
Ezetimibe—ANPEP—nephron tubule—type 2 diabetes mellitus	0.000608	0.0331	CbGeAlD
Ezetimibe—SOAT1—cardiovascular system—type 2 diabetes mellitus	0.000571	0.0311	CbGeAlD
Ezetimibe—SOAT1—pancreas—type 2 diabetes mellitus	0.000555	0.0303	CbGeAlD
Ezetimibe—ANPEP—cardiovascular system—type 2 diabetes mellitus	0.000546	0.0298	CbGeAlD
Ezetimibe—ANPEP—kidney—type 2 diabetes mellitus	0.000535	0.0291	CbGeAlD
Ezetimibe—ANPEP—pancreas—type 2 diabetes mellitus	0.000531	0.0289	CbGeAlD
Ezetimibe—ANPEP—cortex of kidney—type 2 diabetes mellitus	0.000521	0.0284	CbGeAlD
Ezetimibe—SOAT1—adipose tissue—type 2 diabetes mellitus	0.000504	0.0275	CbGeAlD
Ezetimibe—ANPEP—adipose tissue—type 2 diabetes mellitus	0.000482	0.0263	CbGeAlD
Ezetimibe—UGT1A3—liver—type 2 diabetes mellitus	0.000437	0.0238	CbGeAlD
Ezetimibe—UGT2B15—liver—type 2 diabetes mellitus	0.000411	0.0224	CbGeAlD
Ezetimibe—Flunarizine—CALM1—type 2 diabetes mellitus	0.000409	0.279	CrCbGaD
Ezetimibe—UGT2B7—kidney—type 2 diabetes mellitus	0.000397	0.0216	CbGeAlD
Ezetimibe—Pimozide—CALM1—type 2 diabetes mellitus	0.000377	0.257	CrCbGaD
Ezetimibe—SOAT1—liver—type 2 diabetes mellitus	0.000353	0.0193	CbGeAlD
Ezetimibe—ANPEP—liver—type 2 diabetes mellitus	0.000338	0.0184	CbGeAlD
Ezetimibe—UGT1A1—kidney—type 2 diabetes mellitus	0.000338	0.0184	CbGeAlD
Ezetimibe—SLCO1B1—kidney—type 2 diabetes mellitus	0.000281	0.0153	CbGeAlD
Ezetimibe—ABCC3—kidney—type 2 diabetes mellitus	0.000266	0.0145	CbGeAlD
Ezetimibe—UGT2B7—liver—type 2 diabetes mellitus	0.000251	0.0137	CbGeAlD
Ezetimibe—ABCC2—nephron tubule—type 2 diabetes mellitus	0.000242	0.0132	CbGeAlD
Ezetimibe—ABCC3—adipose tissue—type 2 diabetes mellitus	0.00024	0.0131	CbGeAlD
Ezetimibe—Fluspirilene—ADRA2A—type 2 diabetes mellitus	0.000228	0.156	CrCbGaD
Ezetimibe—UGT1A1—liver—type 2 diabetes mellitus	0.000213	0.0116	CbGeAlD
Ezetimibe—ABCC2—kidney—type 2 diabetes mellitus	0.000213	0.0116	CbGeAlD
Ezetimibe—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.000207	0.0113	CbGeAlD
Ezetimibe—SLCO1B1—liver—type 2 diabetes mellitus	0.000178	0.00967	CbGeAlD
Ezetimibe—ABCG2—nephron tubule—type 2 diabetes mellitus	0.000177	0.00963	CbGeAlD
Ezetimibe—ABCC3—liver—type 2 diabetes mellitus	0.000168	0.00918	CbGeAlD
Ezetimibe—ABCG2—adipose tissue—type 2 diabetes mellitus	0.00014	0.00763	CbGeAlD
Ezetimibe—ABCC2—liver—type 2 diabetes mellitus	0.000135	0.00733	CbGeAlD
Ezetimibe—Flunarizine—CYP1A2—type 2 diabetes mellitus	0.000129	0.0878	CrCbGaD
Ezetimibe—Pimozide—CYP2E1—type 2 diabetes mellitus	0.000125	0.0851	CrCbGaD
Ezetimibe—Pimozide—CYP1A2—type 2 diabetes mellitus	0.000119	0.0809	CrCbGaD
Ezetimibe—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000108	0.0059	CbGeAlD
Ezetimibe—CYP3A4—kidney—type 2 diabetes mellitus	0.000108	0.00589	CbGeAlD
Ezetimibe—ABCG2—liver—type 2 diabetes mellitus	9.81e-05	0.00535	CbGeAlD
Ezetimibe—ABCB1—retina—type 2 diabetes mellitus	9.25e-05	0.00504	CbGeAlD
Ezetimibe—ABCB1—nephron tubule—type 2 diabetes mellitus	8.71e-05	0.00475	CbGeAlD
Ezetimibe—Pimozide—CYP3A4—type 2 diabetes mellitus	7.85e-05	0.0536	CrCbGaD
Ezetimibe—ABCB1—cardiovascular system—type 2 diabetes mellitus	7.83e-05	0.00426	CbGeAlD
Ezetimibe—ABCB1—kidney—type 2 diabetes mellitus	7.66e-05	0.00417	CbGeAlD
Ezetimibe—ABCB1—pancreas—type 2 diabetes mellitus	7.61e-05	0.00414	CbGeAlD
Ezetimibe—ABCB1—cortex of kidney—type 2 diabetes mellitus	7.46e-05	0.00406	CbGeAlD
Ezetimibe—ABCB1—adipose tissue—type 2 diabetes mellitus	6.9e-05	0.00376	CbGeAlD
Ezetimibe—CYP3A4—liver—type 2 diabetes mellitus	6.84e-05	0.00373	CbGeAlD
Ezetimibe—Muscle spasms—Losartan—type 2 diabetes mellitus	5.13e-05	0.000646	CcSEcCtD
Ezetimibe—Asthenia—Bromocriptine—type 2 diabetes mellitus	5.12e-05	0.000645	CcSEcCtD
Ezetimibe—Chest pain—Metformin—type 2 diabetes mellitus	5.12e-05	0.000645	CcSEcCtD
Ezetimibe—Myalgia—Metformin—type 2 diabetes mellitus	5.12e-05	0.000645	CcSEcCtD
Ezetimibe—Malaise—Irbesartan—type 2 diabetes mellitus	5.11e-05	0.000644	CcSEcCtD
Ezetimibe—Headache—Pioglitazone—type 2 diabetes mellitus	5.09e-05	0.000641	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	5.08e-05	0.00064	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	5.06e-05	0.000638	CcSEcCtD
Ezetimibe—Discomfort—Metformin—type 2 diabetes mellitus	5.06e-05	0.000637	CcSEcCtD
Ezetimibe—Fatigue—Gliclazide—type 2 diabetes mellitus	5.05e-05	0.000637	CcSEcCtD
Ezetimibe—Nausea—Glipizide—type 2 diabetes mellitus	5.04e-05	0.000635	CcSEcCtD
Ezetimibe—Vomiting—Glimepiride—type 2 diabetes mellitus	5.03e-05	0.000634	CcSEcCtD
Ezetimibe—Vomiting—Sitagliptin—type 2 diabetes mellitus	5.02e-05	0.000632	CcSEcCtD
Ezetimibe—Pain—Gliclazide—type 2 diabetes mellitus	5.01e-05	0.000631	CcSEcCtD
Ezetimibe—Constipation—Gliclazide—type 2 diabetes mellitus	5.01e-05	0.000631	CcSEcCtD
Ezetimibe—Rash—Glimepiride—type 2 diabetes mellitus	4.99e-05	0.000629	CcSEcCtD
Ezetimibe—Dermatitis—Glimepiride—type 2 diabetes mellitus	4.99e-05	0.000628	CcSEcCtD
Ezetimibe—Rash—Sitagliptin—type 2 diabetes mellitus	4.98e-05	0.000627	CcSEcCtD
Ezetimibe—Dermatitis—Sitagliptin—type 2 diabetes mellitus	4.97e-05	0.000626	CcSEcCtD
Ezetimibe—Erythema multiforme—Ramipril—type 2 diabetes mellitus	4.97e-05	0.000626	CcSEcCtD
Ezetimibe—Headache—Glimepiride—type 2 diabetes mellitus	4.96e-05	0.000625	CcSEcCtD
Ezetimibe—Ill-defined disorder—Losartan—type 2 diabetes mellitus	4.95e-05	0.000624	CcSEcCtD
Ezetimibe—Cough—Irbesartan—type 2 diabetes mellitus	4.95e-05	0.000623	CcSEcCtD
Ezetimibe—Headache—Sitagliptin—type 2 diabetes mellitus	4.94e-05	0.000623	CcSEcCtD
Ezetimibe—Anaemia—Losartan—type 2 diabetes mellitus	4.93e-05	0.000621	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	4.91e-05	0.000618	CcSEcCtD
Ezetimibe—Hypertension—Irbesartan—type 2 diabetes mellitus	4.9e-05	0.000617	CcSEcCtD
Ezetimibe—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	4.89e-05	0.000616	CcSEcCtD
Ezetimibe—Flushing—Ramipril—type 2 diabetes mellitus	4.88e-05	0.000615	CcSEcCtD
Ezetimibe—Angioedema—Losartan—type 2 diabetes mellitus	4.88e-05	0.000614	CcSEcCtD
Ezetimibe—Infection—Metformin—type 2 diabetes mellitus	4.87e-05	0.000614	CcSEcCtD
Ezetimibe—Insomnia—Valsartan—type 2 diabetes mellitus	4.87e-05	0.000614	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	4.85e-05	0.000611	CcSEcCtD
Ezetimibe—ABCB1—liver—type 2 diabetes mellitus	4.84e-05	0.00264	CbGeAlD
Ezetimibe—Paraesthesia—Valsartan—type 2 diabetes mellitus	4.84e-05	0.000609	CcSEcCtD
Ezetimibe—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	4.83e-05	0.000609	CcSEcCtD
Ezetimibe—Chest pain—Irbesartan—type 2 diabetes mellitus	4.83e-05	0.000608	CcSEcCtD
Ezetimibe—Arthralgia—Irbesartan—type 2 diabetes mellitus	4.83e-05	0.000608	CcSEcCtD
Ezetimibe—Myalgia—Irbesartan—type 2 diabetes mellitus	4.83e-05	0.000608	CcSEcCtD
Ezetimibe—Insomnia—Orlistat—type 2 diabetes mellitus	4.81e-05	0.000606	CcSEcCtD
Ezetimibe—Malaise—Losartan—type 2 diabetes mellitus	4.81e-05	0.000606	CcSEcCtD
Ezetimibe—Hypersensitivity—Glyburide—type 2 diabetes mellitus	4.81e-05	0.000606	CcSEcCtD
Ezetimibe—Nervous system disorder—Metformin—type 2 diabetes mellitus	4.81e-05	0.000606	CcSEcCtD
Ezetimibe—Thrombocytopenia—Metformin—type 2 diabetes mellitus	4.8e-05	0.000605	CcSEcCtD
Ezetimibe—Dyspnoea—Valsartan—type 2 diabetes mellitus	4.8e-05	0.000605	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	4.8e-05	0.000604	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	4.79e-05	0.000604	CcSEcCtD
Ezetimibe—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.78e-05	0.000602	CcSEcCtD
Ezetimibe—Discomfort—Irbesartan—type 2 diabetes mellitus	4.77e-05	0.000601	CcSEcCtD
Ezetimibe—Skin disorder—Metformin—type 2 diabetes mellitus	4.76e-05	0.0006	CcSEcCtD
Ezetimibe—Immune system disorder—Ramipril—type 2 diabetes mellitus	4.75e-05	0.000598	CcSEcCtD
Ezetimibe—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.74e-05	0.000597	CcSEcCtD
Ezetimibe—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	4.74e-05	0.000597	CcSEcCtD
Ezetimibe—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.72e-05	0.000595	CcSEcCtD
Ezetimibe—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.72e-05	0.000595	CcSEcCtD
Ezetimibe—Palpitations—Losartan—type 2 diabetes mellitus	4.72e-05	0.000594	CcSEcCtD
Ezetimibe—Nausea—Glimepiride—type 2 diabetes mellitus	4.7e-05	0.000592	CcSEcCtD
Ezetimibe—Nausea—Sitagliptin—type 2 diabetes mellitus	4.69e-05	0.00059	CcSEcCtD
Ezetimibe—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.68e-05	0.00059	CcSEcCtD
Ezetimibe—Asthenia—Glyburide—type 2 diabetes mellitus	4.68e-05	0.00059	CcSEcCtD
Ezetimibe—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.68e-05	0.00059	CcSEcCtD
Ezetimibe—Cough—Losartan—type 2 diabetes mellitus	4.66e-05	0.000587	CcSEcCtD
Ezetimibe—Urticaria—Gliclazide—type 2 diabetes mellitus	4.66e-05	0.000587	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.65e-05	0.000586	CcSEcCtD
Ezetimibe—Alopecia—Ramipril—type 2 diabetes mellitus	4.65e-05	0.000585	CcSEcCtD
Ezetimibe—Fatigue—Valsartan—type 2 diabetes mellitus	4.64e-05	0.000585	CcSEcCtD
Ezetimibe—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.63e-05	0.000584	CcSEcCtD
Ezetimibe—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.63e-05	0.000584	CcSEcCtD
Ezetimibe—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	4.63e-05	0.000583	CcSEcCtD
Ezetimibe—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.63e-05	0.000583	CcSEcCtD
Ezetimibe—Pruritus—Glyburide—type 2 diabetes mellitus	4.62e-05	0.000582	CcSEcCtD
Ezetimibe—Mental disorder—Ramipril—type 2 diabetes mellitus	4.61e-05	0.00058	CcSEcCtD
Ezetimibe—Constipation—Valsartan—type 2 diabetes mellitus	4.61e-05	0.00058	CcSEcCtD
Ezetimibe—Infection—Irbesartan—type 2 diabetes mellitus	4.6e-05	0.000579	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.59e-05	0.000579	CcSEcCtD
Ezetimibe—Fatigue—Orlistat—type 2 diabetes mellitus	4.59e-05	0.000578	CcSEcCtD
Ezetimibe—Malnutrition—Ramipril—type 2 diabetes mellitus	4.58e-05	0.000576	CcSEcCtD
Ezetimibe—Erythema—Ramipril—type 2 diabetes mellitus	4.58e-05	0.000576	CcSEcCtD
Ezetimibe—Pain—Orlistat—type 2 diabetes mellitus	4.55e-05	0.000573	CcSEcCtD
Ezetimibe—Arthralgia—Losartan—type 2 diabetes mellitus	4.54e-05	0.000572	CcSEcCtD
Ezetimibe—Chest pain—Losartan—type 2 diabetes mellitus	4.54e-05	0.000572	CcSEcCtD
Ezetimibe—Myalgia—Losartan—type 2 diabetes mellitus	4.54e-05	0.000572	CcSEcCtD
Ezetimibe—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.54e-05	0.000572	CcSEcCtD
Ezetimibe—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.54e-05	0.000572	CcSEcCtD
Ezetimibe—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.53e-05	0.000571	CcSEcCtD
Ezetimibe—Rash—Bromocriptine—type 2 diabetes mellitus	4.5e-05	0.000567	CcSEcCtD
Ezetimibe—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.5e-05	0.000567	CcSEcCtD
Ezetimibe—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.5e-05	0.000566	CcSEcCtD
Ezetimibe—Discomfort—Losartan—type 2 diabetes mellitus	4.49e-05	0.000566	CcSEcCtD
Ezetimibe—Headache—Bromocriptine—type 2 diabetes mellitus	4.47e-05	0.000564	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.47e-05	0.000563	CcSEcCtD
Ezetimibe—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.47e-05	0.000563	CcSEcCtD
Ezetimibe—Dry mouth—Losartan—type 2 diabetes mellitus	4.44e-05	0.00056	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.4e-05	0.000555	CcSEcCtD
Ezetimibe—Paraesthesia—Metformin—type 2 diabetes mellitus	4.4e-05	0.000555	CcSEcCtD
Ezetimibe—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.4e-05	0.000554	CcSEcCtD
Ezetimibe—Confusional state—Losartan—type 2 diabetes mellitus	4.39e-05	0.000553	CcSEcCtD
Ezetimibe—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.39e-05	0.000552	CcSEcCtD
Ezetimibe—Dyspnoea—Metformin—type 2 diabetes mellitus	4.37e-05	0.000551	CcSEcCtD
Ezetimibe—Anaphylactic shock—Losartan—type 2 diabetes mellitus	4.36e-05	0.000549	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.35e-05	0.000548	CcSEcCtD
Ezetimibe—Infection—Losartan—type 2 diabetes mellitus	4.33e-05	0.000545	CcSEcCtD
Ezetimibe—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.32e-05	0.000544	CcSEcCtD
Ezetimibe—Dyspepsia—Metformin—type 2 diabetes mellitus	4.32e-05	0.000544	CcSEcCtD
Ezetimibe—Urticaria—Valsartan—type 2 diabetes mellitus	4.28e-05	0.000539	CcSEcCtD
Ezetimibe—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.27e-05	0.000538	CcSEcCtD
Ezetimibe—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.26e-05	0.000537	CcSEcCtD
Ezetimibe—Decreased appetite—Metformin—type 2 diabetes mellitus	4.26e-05	0.000537	CcSEcCtD
Ezetimibe—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.26e-05	0.000536	CcSEcCtD
Ezetimibe—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	4.25e-05	0.000535	CcSEcCtD
Ezetimibe—Nausea—Bromocriptine—type 2 diabetes mellitus	4.24e-05	0.000534	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.23e-05	0.000533	CcSEcCtD
Ezetimibe—Fatigue—Metformin—type 2 diabetes mellitus	4.23e-05	0.000533	CcSEcCtD
Ezetimibe—Urticaria—Orlistat—type 2 diabetes mellitus	4.23e-05	0.000533	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.22e-05	0.000531	CcSEcCtD
Ezetimibe—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.21e-05	0.00053	CcSEcCtD
Ezetimibe—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.21e-05	0.00053	CcSEcCtD
Ezetimibe—Asthenia—Gliclazide—type 2 diabetes mellitus	4.21e-05	0.00053	CcSEcCtD
Ezetimibe—Constipation—Metformin—type 2 diabetes mellitus	4.19e-05	0.000528	CcSEcCtD
Ezetimibe—Angioedema—Ramipril—type 2 diabetes mellitus	4.18e-05	0.000527	CcSEcCtD
Ezetimibe—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.16e-05	0.000524	CcSEcCtD
Ezetimibe—Vomiting—Glyburide—type 2 diabetes mellitus	4.15e-05	0.000523	CcSEcCtD
Ezetimibe—Pruritus—Gliclazide—type 2 diabetes mellitus	4.15e-05	0.000522	CcSEcCtD
Ezetimibe—Malaise—Ramipril—type 2 diabetes mellitus	4.13e-05	0.00052	CcSEcCtD
Ezetimibe—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.13e-05	0.00052	CcSEcCtD
Ezetimibe—Rash—Glyburide—type 2 diabetes mellitus	4.12e-05	0.000519	CcSEcCtD
Ezetimibe—Dermatitis—Glyburide—type 2 diabetes mellitus	4.11e-05	0.000518	CcSEcCtD
Ezetimibe—Headache—Glyburide—type 2 diabetes mellitus	4.09e-05	0.000515	CcSEcCtD
Ezetimibe—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.07e-05	0.000513	CcSEcCtD
Ezetimibe—Palpitations—Ramipril—type 2 diabetes mellitus	4.04e-05	0.000509	CcSEcCtD
Ezetimibe—Feeling abnormal—Metformin—type 2 diabetes mellitus	4.04e-05	0.000509	CcSEcCtD
Ezetimibe—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.02e-05	0.000507	CcSEcCtD
Ezetimibe—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.01e-05	0.000505	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.01e-05	0.000505	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4e-05	0.000503	CcSEcCtD
Ezetimibe—Cough—Ramipril—type 2 diabetes mellitus	3.99e-05	0.000503	CcSEcCtD
Ezetimibe—Fatigue—Irbesartan—type 2 diabetes mellitus	3.99e-05	0.000503	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	3.97e-05	0.0005	CcSEcCtD
Ezetimibe—Hypersensitivity—Valsartan—type 2 diabetes mellitus	3.97e-05	0.0005	CcSEcCtD
Ezetimibe—Pain—Irbesartan—type 2 diabetes mellitus	3.96e-05	0.000499	CcSEcCtD
Ezetimibe—Constipation—Irbesartan—type 2 diabetes mellitus	3.96e-05	0.000499	CcSEcCtD
Ezetimibe—Insomnia—Losartan—type 2 diabetes mellitus	3.94e-05	0.000496	CcSEcCtD
Ezetimibe—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.92e-05	0.000494	CcSEcCtD
Ezetimibe—Paraesthesia—Losartan—type 2 diabetes mellitus	3.91e-05	0.000493	CcSEcCtD
Ezetimibe—Urticaria—Metformin—type 2 diabetes mellitus	3.9e-05	0.000491	CcSEcCtD
Ezetimibe—Chest pain—Ramipril—type 2 diabetes mellitus	3.9e-05	0.000491	CcSEcCtD
Ezetimibe—Myalgia—Ramipril—type 2 diabetes mellitus	3.9e-05	0.000491	CcSEcCtD
Ezetimibe—Arthralgia—Ramipril—type 2 diabetes mellitus	3.9e-05	0.000491	CcSEcCtD
Ezetimibe—Dyspnoea—Losartan—type 2 diabetes mellitus	3.88e-05	0.000489	CcSEcCtD
Ezetimibe—Nausea—Glyburide—type 2 diabetes mellitus	3.88e-05	0.000488	CcSEcCtD
Ezetimibe—Abdominal pain—Metformin—type 2 diabetes mellitus	3.88e-05	0.000488	CcSEcCtD
Ezetimibe—Dizziness—Gliclazide—type 2 diabetes mellitus	3.88e-05	0.000488	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	3.87e-05	0.000487	CcSEcCtD
Ezetimibe—Asthenia—Valsartan—type 2 diabetes mellitus	3.86e-05	0.000487	CcSEcCtD
Ezetimibe—Discomfort—Ramipril—type 2 diabetes mellitus	3.85e-05	0.000485	CcSEcCtD
Ezetimibe—Dyspepsia—Losartan—type 2 diabetes mellitus	3.83e-05	0.000483	CcSEcCtD
Ezetimibe—Asthenia—Orlistat—type 2 diabetes mellitus	3.82e-05	0.000481	CcSEcCtD
Ezetimibe—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.81e-05	0.00048	CcSEcCtD
Ezetimibe—Pruritus—Valsartan—type 2 diabetes mellitus	3.81e-05	0.00048	CcSEcCtD
Ezetimibe—Dry mouth—Ramipril—type 2 diabetes mellitus	3.81e-05	0.00048	CcSEcCtD
Ezetimibe—Decreased appetite—Losartan—type 2 diabetes mellitus	3.79e-05	0.000477	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.78e-05	0.000477	CcSEcCtD
Ezetimibe—Confusional state—Ramipril—type 2 diabetes mellitus	3.77e-05	0.000474	CcSEcCtD
Ezetimibe—Pruritus—Orlistat—type 2 diabetes mellitus	3.77e-05	0.000474	CcSEcCtD
Ezetimibe—Fatigue—Losartan—type 2 diabetes mellitus	3.76e-05	0.000473	CcSEcCtD
Ezetimibe—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000471	CcSEcCtD
Ezetimibe—Vomiting—Gliclazide—type 2 diabetes mellitus	3.73e-05	0.00047	CcSEcCtD
Ezetimibe—Pain—Losartan—type 2 diabetes mellitus	3.72e-05	0.000469	CcSEcCtD
Ezetimibe—Constipation—Losartan—type 2 diabetes mellitus	3.72e-05	0.000469	CcSEcCtD
Ezetimibe—Rash—Gliclazide—type 2 diabetes mellitus	3.7e-05	0.000466	CcSEcCtD
Ezetimibe—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.69e-05	0.000465	CcSEcCtD
Ezetimibe—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.69e-05	0.000464	CcSEcCtD
Ezetimibe—Urticaria—Irbesartan—type 2 diabetes mellitus	3.68e-05	0.000463	CcSEcCtD
Ezetimibe—Headache—Gliclazide—type 2 diabetes mellitus	3.67e-05	0.000463	CcSEcCtD
Ezetimibe—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.66e-05	0.000461	CcSEcCtD
Ezetimibe—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.66e-05	0.000461	CcSEcCtD
Ezetimibe—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.66e-05	0.000461	CcSEcCtD
Ezetimibe—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.66e-05	0.000461	CcSEcCtD
Ezetimibe—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.64e-05	0.000459	CcSEcCtD
Ezetimibe—Skin disorder—Ramipril—type 2 diabetes mellitus	3.63e-05	0.000457	CcSEcCtD
Ezetimibe—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.59e-05	0.000452	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.56e-05	0.000449	CcSEcCtD
Ezetimibe—Dizziness—Valsartan—type 2 diabetes mellitus	3.56e-05	0.000449	CcSEcCtD
Ezetimibe—Dizziness—Orlistat—type 2 diabetes mellitus	3.52e-05	0.000443	CcSEcCtD
Ezetimibe—Asthenia—Metformin—type 2 diabetes mellitus	3.52e-05	0.000443	CcSEcCtD
Ezetimibe—Nausea—Gliclazide—type 2 diabetes mellitus	3.48e-05	0.000439	CcSEcCtD
Ezetimibe—Pruritus—Metformin—type 2 diabetes mellitus	3.47e-05	0.000437	CcSEcCtD
Ezetimibe—Urticaria—Losartan—type 2 diabetes mellitus	3.46e-05	0.000436	CcSEcCtD
Ezetimibe—Abdominal pain—Losartan—type 2 diabetes mellitus	3.44e-05	0.000434	CcSEcCtD
Ezetimibe—Body temperature increased—Losartan—type 2 diabetes mellitus	3.44e-05	0.000434	CcSEcCtD
Ezetimibe—Vomiting—Valsartan—type 2 diabetes mellitus	3.42e-05	0.000431	CcSEcCtD
Ezetimibe—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.41e-05	0.00043	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.4e-05	0.000429	CcSEcCtD
Ezetimibe—Rash—Valsartan—type 2 diabetes mellitus	3.4e-05	0.000428	CcSEcCtD
Ezetimibe—Dermatitis—Valsartan—type 2 diabetes mellitus	3.39e-05	0.000427	CcSEcCtD
Ezetimibe—Vomiting—Orlistat—type 2 diabetes mellitus	3.38e-05	0.000426	CcSEcCtD
Ezetimibe—Insomnia—Ramipril—type 2 diabetes mellitus	3.38e-05	0.000426	CcSEcCtD
Ezetimibe—Headache—Valsartan—type 2 diabetes mellitus	3.37e-05	0.000425	CcSEcCtD
Ezetimibe—Diarrhoea—Metformin—type 2 diabetes mellitus	3.36e-05	0.000423	CcSEcCtD
Ezetimibe—Rash—Orlistat—type 2 diabetes mellitus	3.36e-05	0.000423	CcSEcCtD
Ezetimibe—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000422	CcSEcCtD
Ezetimibe—Dermatitis—Orlistat—type 2 diabetes mellitus	3.35e-05	0.000422	CcSEcCtD
Ezetimibe—Headache—Orlistat—type 2 diabetes mellitus	3.33e-05	0.00042	CcSEcCtD
Ezetimibe—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.33e-05	0.000419	CcSEcCtD
Ezetimibe—Asthenia—Irbesartan—type 2 diabetes mellitus	3.32e-05	0.000418	CcSEcCtD
Ezetimibe—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.29e-05	0.000414	CcSEcCtD
Ezetimibe—Pruritus—Irbesartan—type 2 diabetes mellitus	3.27e-05	0.000413	CcSEcCtD
Ezetimibe—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.25e-05	0.000409	CcSEcCtD
Ezetimibe—Dizziness—Metformin—type 2 diabetes mellitus	3.24e-05	0.000409	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.22e-05	0.000406	CcSEcCtD
Ezetimibe—Fatigue—Ramipril—type 2 diabetes mellitus	3.22e-05	0.000406	CcSEcCtD
Ezetimibe—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.21e-05	0.000404	CcSEcCtD
Ezetimibe—Nausea—Valsartan—type 2 diabetes mellitus	3.2e-05	0.000403	CcSEcCtD
Ezetimibe—Constipation—Ramipril—type 2 diabetes mellitus	3.19e-05	0.000402	CcSEcCtD
Ezetimibe—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.17e-05	0.000399	CcSEcCtD
Ezetimibe—Nausea—Orlistat—type 2 diabetes mellitus	3.16e-05	0.000398	CcSEcCtD
Ezetimibe—Asthenia—Losartan—type 2 diabetes mellitus	3.13e-05	0.000394	CcSEcCtD
Ezetimibe—Vomiting—Metformin—type 2 diabetes mellitus	3.12e-05	0.000393	CcSEcCtD
Ezetimibe—Rash—Metformin—type 2 diabetes mellitus	3.09e-05	0.00039	CcSEcCtD
Ezetimibe—Dermatitis—Metformin—type 2 diabetes mellitus	3.09e-05	0.000389	CcSEcCtD
Ezetimibe—Pruritus—Losartan—type 2 diabetes mellitus	3.08e-05	0.000388	CcSEcCtD
Ezetimibe—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.08e-05	0.000388	CcSEcCtD
Ezetimibe—Headache—Metformin—type 2 diabetes mellitus	3.07e-05	0.000387	CcSEcCtD
Ezetimibe—Dizziness—Irbesartan—type 2 diabetes mellitus	3.06e-05	0.000386	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.05e-05	0.000385	CcSEcCtD
Ezetimibe—Diarrhoea—Losartan—type 2 diabetes mellitus	2.98e-05	0.000375	CcSEcCtD
Ezetimibe—Urticaria—Ramipril—type 2 diabetes mellitus	2.97e-05	0.000374	CcSEcCtD
Ezetimibe—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.95e-05	0.000372	CcSEcCtD
Ezetimibe—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.95e-05	0.000372	CcSEcCtD
Ezetimibe—Vomiting—Irbesartan—type 2 diabetes mellitus	2.94e-05	0.000371	CcSEcCtD
Ezetimibe—Rash—Irbesartan—type 2 diabetes mellitus	2.92e-05	0.000368	CcSEcCtD
Ezetimibe—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.92e-05	0.000367	CcSEcCtD
Ezetimibe—Nausea—Metformin—type 2 diabetes mellitus	2.91e-05	0.000367	CcSEcCtD
Ezetimibe—Headache—Irbesartan—type 2 diabetes mellitus	2.9e-05	0.000365	CcSEcCtD
Ezetimibe—Dizziness—Losartan—type 2 diabetes mellitus	2.88e-05	0.000363	CcSEcCtD
Ezetimibe—Vomiting—Losartan—type 2 diabetes mellitus	2.77e-05	0.000349	CcSEcCtD
Ezetimibe—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.75e-05	0.000347	CcSEcCtD
Ezetimibe—Nausea—Irbesartan—type 2 diabetes mellitus	2.75e-05	0.000346	CcSEcCtD
Ezetimibe—Rash—Losartan—type 2 diabetes mellitus	2.75e-05	0.000346	CcSEcCtD
Ezetimibe—Dermatitis—Losartan—type 2 diabetes mellitus	2.74e-05	0.000346	CcSEcCtD
Ezetimibe—Headache—Losartan—type 2 diabetes mellitus	2.73e-05	0.000344	CcSEcCtD
Ezetimibe—Asthenia—Ramipril—type 2 diabetes mellitus	2.68e-05	0.000338	CcSEcCtD
Ezetimibe—Pruritus—Ramipril—type 2 diabetes mellitus	2.64e-05	0.000333	CcSEcCtD
Ezetimibe—Nausea—Losartan—type 2 diabetes mellitus	2.59e-05	0.000326	CcSEcCtD
Ezetimibe—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.56e-05	0.000322	CcSEcCtD
Ezetimibe—Dizziness—Ramipril—type 2 diabetes mellitus	2.47e-05	0.000311	CcSEcCtD
Ezetimibe—Vomiting—Ramipril—type 2 diabetes mellitus	2.37e-05	0.000299	CcSEcCtD
Ezetimibe—Rash—Ramipril—type 2 diabetes mellitus	2.36e-05	0.000297	CcSEcCtD
Ezetimibe—Dermatitis—Ramipril—type 2 diabetes mellitus	2.35e-05	0.000296	CcSEcCtD
Ezetimibe—Headache—Ramipril—type 2 diabetes mellitus	2.34e-05	0.000295	CcSEcCtD
Ezetimibe—Nausea—Ramipril—type 2 diabetes mellitus	2.22e-05	0.000279	CcSEcCtD
Ezetimibe—UGT1A1—Metabolism—GNB3—type 2 diabetes mellitus	2.32e-06	3.65e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.32e-06	3.65e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—HMOX1—type 2 diabetes mellitus	2.31e-06	3.63e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PPARA—type 2 diabetes mellitus	2.3e-06	3.61e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PPARA—type 2 diabetes mellitus	2.3e-06	3.61e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GCG—type 2 diabetes mellitus	2.29e-06	3.59e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.29e-06	3.59e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CAT—type 2 diabetes mellitus	2.28e-06	3.59e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.27e-06	3.58e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.26e-06	3.56e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	2.25e-06	3.54e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	2.25e-06	3.54e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.24e-06	3.53e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PPARG—type 2 diabetes mellitus	2.23e-06	3.51e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AGT—type 2 diabetes mellitus	2.23e-06	3.5e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AGT—type 2 diabetes mellitus	2.23e-06	3.5e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—APOB—type 2 diabetes mellitus	2.21e-06	3.48e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	2.21e-06	3.48e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—INS—type 2 diabetes mellitus	2.19e-06	3.45e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CALM1—type 2 diabetes mellitus	2.19e-06	3.44e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CALM1—type 2 diabetes mellitus	2.19e-06	3.44e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—APOE—type 2 diabetes mellitus	2.18e-06	3.43e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—APOE—type 2 diabetes mellitus	2.18e-06	3.43e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.17e-06	3.41e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	2.16e-06	3.41e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—APOA1—type 2 diabetes mellitus	2.16e-06	3.39e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—APOA1—type 2 diabetes mellitus	2.16e-06	3.39e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GSTM1—type 2 diabetes mellitus	2.15e-06	3.39e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	2.15e-06	3.37e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GNB3—type 2 diabetes mellitus	2.13e-06	3.35e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.13e-06	3.35e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	2.12e-06	3.34e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—HMOX1—type 2 diabetes mellitus	2.12e-06	3.33e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—LPL—type 2 diabetes mellitus	2.11e-06	3.32e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CAT—type 2 diabetes mellitus	2.09e-06	3.29e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	2.07e-06	3.26e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ADCY5—type 2 diabetes mellitus	2.07e-06	3.25e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GPX1—type 2 diabetes mellitus	2.06e-06	3.24e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—APOB—type 2 diabetes mellitus	2.03e-06	3.19e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.03e-06	3.19e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	2.02e-06	3.18e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ALB—type 2 diabetes mellitus	2.01e-06	3.16e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CD36—type 2 diabetes mellitus	2.01e-06	3.16e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	2e-06	3.15e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	2e-06	3.15e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	2e-06	3.15e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	2e-06	3.15e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.98e-06	3.12e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.98e-06	3.11e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.98e-06	3.11e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTM1—type 2 diabetes mellitus	1.97e-06	3.1e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.97e-06	3.1e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GNB3—type 2 diabetes mellitus	1.97e-06	3.1e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—HMOX1—type 2 diabetes mellitus	1.96e-06	3.08e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—LPL—type 2 diabetes mellitus	1.94e-06	3.05e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CAT—type 2 diabetes mellitus	1.93e-06	3.04e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—NOS3—type 2 diabetes mellitus	1.92e-06	3.02e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3R1—type 2 diabetes mellitus	1.92e-06	3.02e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.92e-06	3.02e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.91e-06	3.01e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.91e-06	3.01e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.91e-06	3.01e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.91e-06	3.01e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.91e-06	3.01e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—MTHFR—type 2 diabetes mellitus	1.9e-06	2.99e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PPARG—type 2 diabetes mellitus	1.9e-06	2.99e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PPARG—type 2 diabetes mellitus	1.9e-06	2.99e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ADCY5—type 2 diabetes mellitus	1.9e-06	2.98e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GPX1—type 2 diabetes mellitus	1.89e-06	2.97e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APOB—type 2 diabetes mellitus	1.88e-06	2.95e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PPARA—type 2 diabetes mellitus	1.87e-06	2.94e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—INS—type 2 diabetes mellitus	1.86e-06	2.93e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—INS—type 2 diabetes mellitus	1.86e-06	2.93e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.85e-06	2.91e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CD36—type 2 diabetes mellitus	1.84e-06	2.89e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.83e-06	2.88e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTM1—type 2 diabetes mellitus	1.83e-06	2.87e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.82e-06	2.86e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AGT—type 2 diabetes mellitus	1.81e-06	2.84e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—LPL—type 2 diabetes mellitus	1.79e-06	2.82e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	1.78e-06	2.8e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CALM1—type 2 diabetes mellitus	1.78e-06	2.8e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—APOE—type 2 diabetes mellitus	1.77e-06	2.79e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTGS2—type 2 diabetes mellitus	1.76e-06	2.76e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ADCY5—type 2 diabetes mellitus	1.76e-06	2.76e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—APOA1—type 2 diabetes mellitus	1.75e-06	2.75e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GPX1—type 2 diabetes mellitus	1.75e-06	2.75e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.75e-06	2.75e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.75e-06	2.75e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—MTHFR—type 2 diabetes mellitus	1.74e-06	2.74e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.72e-06	2.7e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PPARA—type 2 diabetes mellitus	1.71e-06	2.69e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ALB—type 2 diabetes mellitus	1.71e-06	2.69e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ALB—type 2 diabetes mellitus	1.71e-06	2.69e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.7e-06	2.68e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CD36—type 2 diabetes mellitus	1.7e-06	2.68e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.68e-06	2.65e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.66e-06	2.62e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AGT—type 2 diabetes mellitus	1.66e-06	2.61e-05	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AKT1—type 2 diabetes mellitus	1.65e-06	2.59e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3R1—type 2 diabetes mellitus	1.63e-06	2.57e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—NOS3—type 2 diabetes mellitus	1.63e-06	2.57e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—NOS3—type 2 diabetes mellitus	1.63e-06	2.57e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3R1—type 2 diabetes mellitus	1.63e-06	2.57e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	1.63e-06	2.56e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	1.63e-06	2.56e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CALM1—type 2 diabetes mellitus	1.63e-06	2.56e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.63e-06	2.56e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.63e-06	2.56e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.63e-06	2.56e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—APOE—type 2 diabetes mellitus	1.62e-06	2.55e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—MTHFR—type 2 diabetes mellitus	1.61e-06	2.54e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—APOA1—type 2 diabetes mellitus	1.6e-06	2.52e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	1.6e-06	2.51e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	1.59e-06	2.5e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	1.59e-06	2.5e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	1.59e-06	2.5e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PPARA—type 2 diabetes mellitus	1.58e-06	2.49e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.58e-06	2.48e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.56e-06	2.45e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.56e-06	2.45e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.55e-06	2.44e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PPARG—type 2 diabetes mellitus	1.54e-06	2.43e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AGT—type 2 diabetes mellitus	1.53e-06	2.41e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	1.53e-06	2.41e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—INS—type 2 diabetes mellitus	1.51e-06	2.38e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CALM1—type 2 diabetes mellitus	1.51e-06	2.37e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.5e-06	2.37e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APOE—type 2 diabetes mellitus	1.5e-06	2.36e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.5e-06	2.36e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.5e-06	2.36e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTGS2—type 2 diabetes mellitus	1.49e-06	2.35e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTGS2—type 2 diabetes mellitus	1.49e-06	2.35e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APOA1—type 2 diabetes mellitus	1.49e-06	2.34e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.47e-06	2.32e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.45e-06	2.28e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.45e-06	2.28e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.45e-06	2.28e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	1.43e-06	2.24e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	1.43e-06	2.24e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	1.43e-06	2.24e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PPARG—type 2 diabetes mellitus	1.41e-06	2.22e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	1.4e-06	2.2e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ALB—type 2 diabetes mellitus	1.39e-06	2.18e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	1.39e-06	2.18e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	1.39e-06	2.18e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.36e-06	2.14e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.36e-06	2.14e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.36e-06	2.13e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.33e-06	2.09e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—NOS3—type 2 diabetes mellitus	1.33e-06	2.09e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PPARG—type 2 diabetes mellitus	1.31e-06	2.06e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.3e-06	2.05e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.29e-06	2.03e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.29e-06	2.03e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—INS—type 2 diabetes mellitus	1.28e-06	2.02e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.28e-06	2.01e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	1.27e-06	2e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.26e-06	1.98e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	1.24e-06	1.94e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.24e-06	1.94e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.23e-06	1.94e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.23e-06	1.94e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.23e-06	1.94e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.23e-06	1.94e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.22e-06	1.91e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	1.22e-06	1.91e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.21e-06	1.91e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1.18e-06	1.86e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	1.18e-06	1.85e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	1.13e-06	1.77e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.13e-06	1.77e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	1.11e-06	1.75e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	1.1e-06	1.73e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	1.06e-06	1.68e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.06e-06	1.68e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.06e-06	1.67e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	1.05e-06	1.65e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	1.03e-06	1.62e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.03e-06	1.61e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.02e-06	1.6e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1e-06	1.58e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1e-06	1.58e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	9.88e-07	1.55e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	9.85e-07	1.55e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	9.79e-07	1.54e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	9.79e-07	1.54e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	9.79e-07	1.54e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	9.73e-07	1.53e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	9.7e-07	1.53e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	9.55e-07	1.5e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	9.49e-07	1.49e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	9.46e-07	1.49e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	9.44e-07	1.49e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	9.21e-07	1.45e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	9.1e-07	1.43e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AKT1—type 2 diabetes mellitus	8.83e-07	1.39e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	8.78e-07	1.38e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	8.78e-07	1.38e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	8.78e-07	1.38e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	8.73e-07	1.37e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	8.62e-07	1.36e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	8.56e-07	1.35e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	8.54e-07	1.34e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	8.36e-07	1.31e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	8.29e-07	1.3e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	8.16e-07	1.28e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	8.13e-07	1.28e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	8.03e-07	1.26e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	8.03e-07	1.26e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	7.94e-07	1.25e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	7.94e-07	1.25e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	7.61e-07	1.2e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	7.61e-07	1.2e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AKT1—type 2 diabetes mellitus	7.51e-07	1.18e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AKT1—type 2 diabetes mellitus	7.51e-07	1.18e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	7.08e-07	1.11e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—INS—type 2 diabetes mellitus	6.94e-07	1.09e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	6.56e-07	1.03e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.56e-07	1.03e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	6.53e-07	1.03e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	6.44e-07	1.01e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	6.36e-07	1e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	6.26e-07	9.84e-06	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AKT1—type 2 diabetes mellitus	6.1e-07	9.6e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	6.09e-07	9.58e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	6.09e-07	9.58e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	6.09e-07	9.57e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	5.97e-07	9.4e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	5.85e-07	9.2e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	5.83e-07	9.17e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	5.68e-07	8.93e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	5.6e-07	8.82e-06	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	5.59e-07	8.79e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	5.57e-07	8.76e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	5.38e-07	8.46e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	5.28e-07	8.3e-06	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	5.18e-07	8.14e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	5.11e-07	8.04e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	5.02e-07	7.9e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	5.01e-07	7.88e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	4.95e-07	7.79e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	4.36e-07	6.86e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	4.28e-07	6.73e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.92e-07	6.17e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.75e-07	5.9e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3.75e-07	5.9e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	3.43e-07	5.4e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	2.8e-07	4.4e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.72e-07	2.71e-06	CbGpPWpGaD
